UltraGreen.ai Limited manufactures and sells Indocyanine Green (ICG) pharmaceutical products in the United States and internationally. It provides diagnostic imaging analytics and software solutions. The company also develops software for real-time quantification of blood perfusion during surgery, including PerfusionWorks quantification software for tissue perfusion, lymphatic mapping, and margin assessment. In addition, it offers products, such as ICG, the IC-Flow Imaging System and the UltraGreen Data Platform and other technologies related to fluorescence guided surgery. Further, the company sells ICG vials and related pharmaceutical products; and engages in software development activities. It serves healthcare providers, hospitals, and medical technology companies. The company was formerly known as UltraGreen.ai Private Limited and changed its name to UltraGreen.ai Limited. UltraGreen.ai Limited was incorporated in 2024 and is based in Singapore. UltraGreen.ai Limited operates as a subsidiary of Renew Group Private Limited.
Metrics to compare | ULTR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipULTRPeersSector | |
|---|---|---|---|---|
P/E Ratio | 33.2x | 17.4x | −0.5x | |
PEG Ratio | −0.33 | −0.34 | 0.00 | |
Price/Book | 5.5x | 1.5x | 2.6x | |
Price / LTM Sales | 12.3x | 1.6x | 3.1x | |
Upside (Analyst Target) | 29.9% | 19.0% | 53.1% | |
Fair Value Upside | Unlock | 29.1% | 7.1% | Unlock |